TW200806314A - Immunogenic composition - Google Patents

Immunogenic composition

Info

Publication number
TW200806314A
TW200806314A TW96110815A TW96110815A TW200806314A TW 200806314 A TW200806314 A TW 200806314A TW 96110815 A TW96110815 A TW 96110815A TW 96110815 A TW96110815 A TW 96110815A TW 200806314 A TW200806314 A TW 200806314A
Authority
TW
Taiwan
Prior art keywords
immunogenic composition
type
pnag
oligosaccharide
aureus
Prior art date
Application number
TW96110815A
Other languages
Chinese (zh)
Other versions
TWI494124B (en
Inventor
Ralph Leon Biemans
Philippe Denoel
Pierre Duvivier
Tomas Maira-Litran
Jan Poolman
Original Assignee
Glaxosmithkline Biolog Sa
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43217117&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200806314(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0606416A external-priority patent/GB0606416D0/en
Priority claimed from GB0606417A external-priority patent/GB0606417D0/en
Application filed by Glaxosmithkline Biolog Sa, Brigham & Womens Hospital filed Critical Glaxosmithkline Biolog Sa
Publication of TW200806314A publication Critical patent/TW200806314A/en
Application granted granted Critical
Publication of TWI494124B publication Critical patent/TWI494124B/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present application relates to immunogenic compositions comprising staphylococcal PNAG conjugate and Type 5 and/or 8 capular polysaccharide or oligosaccharide from S. aureus. Vaccines, methods of treatment using and processes to make an immunogenic composition comprising PNAG and Type 5 and/or 8 capsular polysaccharides are also described.
TW096110815A 2006-03-30 2007-03-28 Immunogenic composition TWI494124B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US78758706P 2006-03-30 2006-03-30
US78724906P 2006-03-30 2006-03-30
GB0606416A GB0606416D0 (en) 2006-03-30 2006-03-30 Immunogenic composition
GB0606417A GB0606417D0 (en) 2006-03-30 2006-03-30 Immunogenic composition

Publications (2)

Publication Number Publication Date
TW200806314A true TW200806314A (en) 2008-02-01
TWI494124B TWI494124B (en) 2015-08-01

Family

ID=43217117

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096110815A TWI494124B (en) 2006-03-30 2007-03-28 Immunogenic composition

Country Status (4)

Country Link
CL (1) CL2007000839A1 (en)
JO (2) JO3420B1 (en)
PE (3) PE20080774A1 (en)
TW (1) TWI494124B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102120761A (en) * 2010-12-24 2011-07-13 新疆维吾尔自治区畜牧科学院兽医研究所 Acapsular type staphylococcus aureus extracellular polysaccharide-protein conjugate and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60038166T2 (en) * 1999-03-19 2009-03-12 Glaxosmithkline Biologicals S.A., Rixensart VACCINE AGAINST BACTERIAL ANTIGENE
WO2004080490A2 (en) * 2003-03-07 2004-09-23 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
WO2005000346A1 (en) * 2003-06-23 2005-01-06 Baxter International Inc. Carrier proteins for vaccines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102120761A (en) * 2010-12-24 2011-07-13 新疆维吾尔自治区畜牧科学院兽医研究所 Acapsular type staphylococcus aureus extracellular polysaccharide-protein conjugate and preparation method thereof
CN102120761B (en) * 2010-12-24 2013-02-06 新疆维吾尔自治区畜牧科学院兽医研究所 Preparation method of acapsular type staphylococcus aureus extracellular polysaccharide-protein conjugate

Also Published As

Publication number Publication date
PE20120262A1 (en) 2012-03-30
JO3420B1 (en) 2019-10-20
PE20080774A1 (en) 2008-08-08
JO3418B1 (en) 2019-10-20
CL2007000839A1 (en) 2008-01-25
TWI494124B (en) 2015-08-01
PE20080129A1 (en) 2008-04-08

Similar Documents

Publication Publication Date Title
WO2006032500A3 (en) Immunogenic composition
MY148405A (en) Immunogenic composition
WO2007113223A3 (en) Immunogenic composition
PH12015502508A1 (en) Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
MX2017014127A (en) Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof.
MX2010003258A (en) Use of a novel natural agent in cosmetic compositions.
PH12014502544A1 (en) Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
GB201101665D0 (en) Immunogenic compositions
EA201391788A1 (en) VACCINE CONTAINING CONJUGATES OF CAPSULAR POLYSACCHARIDES STREPTOCOCCUS PNEUMONIAE
EA200702574A1 (en) IMMUNOGENIC COMPOSITION
MX2007010771A (en) Angiogenic heparin binding peptide amphiphiles.
MX2010010726A (en) Hair styling composition.
MX2009003378A (en) Suspension concentrates for improving the root absorption of agrochemical active ingredients.
PL1965809T3 (en) Compositions to improve gut health and animal performance comprising beta-glucans and alfa-fucans
IN2014DN09791A (en)
TW200514569A (en) Vaccine composition
CL2012000744A1 (en) Process for preparing a type 5 or type 8 capsular polysaccharide conjugate of s. aureus and a carrier molecule; polysaccharide conjugate; and an immunogenic composition comprising it.
WO2006128089A3 (en) Compositions and methods for treating tissue
ZA202310611B (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
UA97359C2 (en) Immunogenic composition
AR060182A1 (en) TYPE 5 AND TYPE 8 CAPSULAR POLISACARIDS OF CEPAS S. AUREUS OF OVERPRODUCTION
TW200806314A (en) Immunogenic composition
BR112017028395A2 (en) "Bacterial capsular polysaccharide, conjugate, and pharmaceutical composition"
WO2008084533A1 (en) Therapeutic agent for meniere’s disease
UA95075C2 (en) Immunogenic composition